IMR Press / CEOG / Volume 40 / Issue 2 / pii/1630388195011-1806400047

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Gonadotropinoma presenting as a case of pseudo-ovarian failure changing to macroprolactinoma
Show Less
1 The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology Division of Reproductive Endocrinology and Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2013, 40(2), 295–296;
Published: 10 June 2013
Abstract

Purpose: To present the first gonadotropinoma presenting as pseudo-menopause in a teenager. Methods: Human menopausal gonadotropins (hMG) were given to a 37-year-old woman whose hypergonadotropic amenorrhea with estrogen deficiency as a teenager was changed to hypogonadotropic amenorrhea by the growth and prolactin secretion of a macroprolactinoma. Results: The patient responded multiple times, and every time to stimulation with hMG and each time produced several dominant follicles. She delivered two babies including conception at age 40. Conclusions: The fact that this woman could respond consistently to hMG 20 years after the diagnosis of premature menopause, it is clear that initially the etiology of the extremely high LH and FSH levels in an estrogen-deficient 18-year-old was the presence of gonadotropinoma secreting inert LH and FSH. Since serum prolactin was measured the first time at age 37, it is not clear whether the endogenous biologically active gonadotropine were suppressed by replacement of the gonadotroph cells with tumor cells or suppression of endogenous gonadotropins by hyperprolactinoma.
Keywords
Gonadotropinoma
Hyperprolactinoma
Pituitary macroadenoma
Ovarian failure
Hypergonadotropic amenorrhea
Share
Back to top